Blog

Pam Mangat-Dhaliwal: Thrilled to participate in the second ASCO-AIOM International Clinical Research Course

Photo taken from Pam Mangat-Dhaliwal/LinkedIn

Apr 17, 2024, 17:32

Pam Mangat-Dhaliwal: Thrilled to participate in the second ASCO-AIOM International Clinical Research Course

Dario Trapani, Medical oncologist at the European Institute of Oncology (IEO), shared a post by Pam Mangat-Dhaliwal, Division Director of Clinical Research and Analytics at ASCO, on LinkedIn:

“This is an incredible ensamble of the IT and UM cancer societies convene (not second edition!) for the clinical trial methodology course!

Amazing to see you all back in Rome and hope this to become a new tradition for the workforce training & research empowerment! ”

Quoting Pam Mangat-Dhaliwal‘s post:

“Thrilled to participate in the second ASCO-AIOM International Clinical Research Course. The American Society of Clinical Oncology (ASCO) is committed to its mission in making a global impact which involves lifting up the next generation of oncologists in clinical research, as is AIOM | Associazione Italiana di Oncologia Medica. Honored to be part of this collaboration with AIOM. This year’s course was a great success! ”

Pam Mangat-Dhaliwal

Source: Dario Trapani/LinkedIn and Pam Mangat-Dhaliwal/LinkedIn

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.